1.中国中医科学院广安门医院,北京市西城区北线阁5号,100053
2.北京中医药大学
通信作者:gamyylj@163.com
收稿:2025-04-27,
修回:2025-07-16,
纸质出版:2026-02-02
移动端阅览
李永浩,李军,王禹童等.运用补肾活血荣脉法分期防治冠状动脉旁路移植术术后静脉桥闭塞[J].中医杂志,2026,67(03):323-326.
LI Yonghao,LI Jun,WANG Yutong,et al.Staged Prevention and Treatment of Vein Graft Occlusion After Coronary Artery Bypass Grafting Using the Method of Tonifying Kidney,Activating Blood,and Nourishing the Vessels[J].Journal of Traditional Chinese Medicine,2026,67(03):323-326.
李永浩,李军,王禹童等.运用补肾活血荣脉法分期防治冠状动脉旁路移植术术后静脉桥闭塞[J].中医杂志,2026,67(03):323-326. DOI: 10.13288/j.11-2166/r.2026.03.014.
LI Yonghao,LI Jun,WANG Yutong,et al.Staged Prevention and Treatment of Vein Graft Occlusion After Coronary Artery Bypass Grafting Using the Method of Tonifying Kidney,Activating Blood,and Nourishing the Vessels[J].Journal of Traditional Chinese Medicine,2026,67(03):323-326. DOI: 10.13288/j.11-2166/r.2026.03.014.
基于中医学肾与血脉的密切联系,探讨冠状动脉旁路移植术(CABG)术后静脉桥闭塞的中医分期防治策略。提出以“补肾活血荣脉法”为核心治法,以丹桂补肾活血方为基础方。在此基础上结合术后早期血栓形成、中期内膜增生及晚期桥血管粥样硬化的病理特点,进行分期施治,早期侧重益气以帅血防栓,中期侧重化痰祛瘀以通络,晚期侧重填精消浊以固本荣脉,为中医药防治CABG术后静脉桥闭塞提供思路。
Based on the close relationship between the kidney and the blood vessels in traditional Chinese medicine (TCM), this paper explores TCM-based staged prevention and treatment strategies for vein graft occlusion after coronary artery bypass grafting (CABG). The core therapeutic approach is the method of "tonifying the kidney, activating blood, and nourishing the vessels", with the
Dangui Bushen Huoxue Fomulation
(丹桂补肾活血方) as the base formula. On this basis, treatment is staged according to the pathological features of early postoperative thrombosis, mid-term intimal hyperplasia, and late-stage graft atherosclerosis. In the early stage, emphasis is placed on tonifying
qi
to manage blood and prevent thrombosis; in the mid-term stage, focus is on resolving phlegm and removing blood stasis to open the collaterals; in the late stage, emphasis is on replenishing essence and eliminating turbidity to conso-lidate the root and nourish the vessels. This provides a TCM framework for preventing and treating vein graft occlusion after CABG.
CIEZA A , CAUSEY K , KAMENOV K , et al . Global estimates of the need for rehabilitation based on the global burden of disease study 2019: a systematic analysis for the global burden of disease study 2019 [J]. Lancet , 2021 , 396 ( 10267 ): 2006 - 2017 .
LAWTON JS , TAMIS-HOLLAND JE , BANGALORE S , et al . 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [J]. J Am Coll Cardiol , 2022 , 79 ( 2 ): e21 - e129 .
XENOGIANNIS I , ZENATI M , BHATT DL , et al . Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies [J]. Circulation , 2021 , 144 ( 9 ): 728 - 745 .
赵志强 , 王贤良 , 苏全 , 等 . 血运重建时代中医药在冠心病治疗中的应用 [J]. 中国中西医结合杂志 , 2018 , 38 ( 5 ): 614 - 617 .
刘小丽 . 护心方对冠脉搭桥术后桥血管远期通畅率影响的临床研究 [D]. 广州 : 广州中医药大学 , 2014 .
刘超 , 王阶 . 从补肾对血脉的影响探讨其在冠心病治疗中的应用与研究 [J]. 中华中医药杂志 , 2018 , 33 ( 3 ): 841 - 843 .
何庆勇 , 王阶 , 姚魁武 , 等 . 1069例冠心病脏腑虚证的多中心前瞻性研究 [J]. 中华中医药杂志 , 2009 , 24 ( 1 ): 31 - 33 .
National Kidney Foundation . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification [J]. Am J Kidney Dis , 2002 , 39 (2 Suppl 1 ): 1 - 266 .
NEUMANN FJ , SOUSA-UVA M , AHLSSON A , et al . 2018 ESC/EACTS Guidelines on myocardial revascularization [J]. Eur Heart J , 2019 , 40 ( 2 ): 87 - 165 .
JIN D , TAKAI S , LI Z , et al . Outside fibroblasts play a key role in the development of inner neointima after the implantation of polytetrafluoroethylene grafts [J]. J Pharmacol Sci , 2012 , 119 ( 2 ): 139 - 149 .
吴芸 , 周淑妮 . 冠心病不稳定型心绞痛患者中医证型分布及其与Gensini评分、炎症因子的关系 [J]. 四川中医 , 2021 , 39 ( 10 ): 63 - 66 .
HANSSON GK , GENG YJ , HOLM J , et al . Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injurys [J]. J Exp Med , 1994 , 180 ( 2 ): 733 - 738 .
SUR S , SUGIMOTO JT , AGRAWAL DK . Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia? [J]. Can J Physiol Pharmacol , 2014 , 92 ( 7 ): 531 - 545 .
刘德川 , 柏冰 , 王科 , 等 . 补肾活血组方穴位定向透药预防全髋关节置换术后下肢深静脉血栓临床观察 [J]. 光明中医 , 2023 , 38 ( 9 ): 1701 - 1703 .
赵佳琳 , 陈萍 , 徐广立 , 等 . 补肾活血方通过下调JAK2/STAT3通路改善小鼠的复发性流产 [J]. 南方医科大学学报 , 2023 , 43 ( 2 ): 265 - 270 .
王小兰 , 李孟 , 孙墨 , 等 . 地黄中毛蕊花糖苷对OxLDL诱导的人脐静脉内皮细胞凋亡与自噬的影响 [J]. 中药材 , 2023 , 46 ( 1 ): 186 - 190 .
梁天成 , 黄家应 , 向友 , 等 . 补肾生血药促进大鼠缺血后肢血管新生的实验研究 [J]. 中国现代普通外科进展 , 2006 , 9 ( 3 ): 165 - 167 .
潘小龙 . 芪芎左归饮对老年缺血性脑卒中恢复期患者临床疗效及血清VEGF、Ang-1水平的影响 [D]. 郑州 : 河南中医药大学 , 2023 .
GUO P , WANG X , CHEN Q , et al . Integrative metabolomics and proteomics reveal the effects and mechanisms of Salvia miltiorrhiza in alleviating traumatic blood stasis syndrome [J]. Front Vet Sci , 2025 , 12 : 1579790 . doi: 10.3389/fvets.2025.1579790 http://dx.doi.org/10.3389/fvets.2025.1579790 .
BI C , LI PL , LIAO Y , et al . Pharmacodynamic effects of Dan-hong injection in rats with blood stasis syndrome [J]. Biomed Pharmacother , 2019 , 118 : 109187 . doi: 10. 1016/j.biopha.2019.109187 http://dx.doi.org/10.1016/j.biopha.2019.109187 .
陈社带 , 邹燕 , 赵伟国 , 等 . 三七总皂苷对大鼠缺血心肌血管新生及相关生长因子的影响 [J]. 辽宁医学院学报 , 2015 , 36 ( 1 ): 7 - 9 .
韩利平 , 王天珩 , 曹利波 , 等 . 川芎嗪对ApoE -/- 小鼠动脉粥样硬化斑块的影响及机制 [J]. 中国动脉硬化杂志 , 2025 , 33 ( 8 ): 673 - 682 .
刘玲 , 李瑞芳 , 王 等 , 等 . 芍药苷减轻LPS致小鼠急性脑损伤的抗炎机制 [J]. 中药材 , 2016 , 39 ( 2 ): 411 - 415 .
李军 , 孙语男 , 王阶 . 基于“血管-脏腑-证治”防治泛血管疾病的中医思考 [J]. 中国实验方剂学杂志 , 2024 , 30 ( 10 ): 187 - 195 .
缪化春 , 沈业寿 . 天麻多糖的降血压作用 [J]. 高血压杂志 , 2006 , 14 ( 7 ): 531 - 534 .
郭梦婷 , 吕孝旺 , 王志玮 , 等 . 葛根素对肥胖小鼠血压和主动脉内皮功能的影响 [J]. 中国药理学通报 , 2022 , 38 ( 10 ): 1492 - 1497 .
韩寿龙 , 齐汝霞 , 张鹏 , 等 . 桑寄生提取物对肾性高血压大鼠降压作用的初步研究 [J]. 基层中医药 , 2023 , 2 ( 8 ): 82 - 86 .
赵卓 , 高浩 , 杨莹 , 等 . 绞股蓝皂苷抑制Bcl2L12凋亡通路改善ApoE -/- 动脉粥样硬化小鼠肝脏脂质沉积 [J]. 中国中西医结合杂志 , 2023 , 43 ( 10 ): 1221 - 1227 .
周大伟 . 中药红曲对高脂饮食大鼠血脂的影响作用 [J]. 中国当代医药 , 2014 , 21 ( 16 ): 19 - 21 .
张建平 , 严士海 . 二苯乙烯苷抑制apoE -/- 小鼠动脉粥样硬化的机理研究 [J]. 中华中医药学刊 , 2015 , 33 ( 9 ): 2086 - 2088 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号